Allianz SE
MIL:1ALV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Allianz SE
MIL:1ALV
|
DE |
|
O
|
Organigram Global Inc
F:0OG
|
CA |
|
C
|
Celldex Therapeutics Inc
SWB:TCE2
|
US |
|
F
|
Federal Home Loan Mortgage Corp
SWB:FHL
|
US |
|
B
|
Banco Santander SA
XMUN:BSD2
|
ES |
|
M
|
Microbot Medical Inc
F:CY9D
|
US |
|
U
|
Universal Technical Institute Inc
F:UTI
|
US |
|
Molson Coors Beverage Co
F:NY70
|
US |
|
M
|
Muenchener Rueckversicherungs Gesellschaft in Muenchen AG
F:MUV2
|
DE |
|
S
|
Sandvik AB
XMUN:SVKB
|
SE |
|
WuXi Biologics (Cayman) Inc
F:1FW1
|
CN |
|
E
|
Eltel AB
SWB:E5E
|
SE |
|
I
|
Ionis Pharmaceuticals Inc
F:ISI
|
US |
|
Jiangxi Copper Co Ltd
SSE:600362
|
CN |
Wall St Price Targets
1ALV Price Targets Summary
Allianz SE
According to Wall Street analysts, the average 1-year price target for 1ALV is 458.17 EUR with a low forecast of 327.66 EUR and a high forecast of 716.9 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1ALV's stock price target?
Price Target
458.17
EUR
According to Wall Street analysts, the average 1-year price target for 1ALV is 458.17 EUR with a low forecast of 327.66 EUR and a high forecast of 716.9 EUR.
What is the Revenue forecast for Allianz SE?
Projected CAGR
19%
Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 5 years is 19%.
What is the Net Income forecast for Allianz SE?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 5 years is 4%.